Rice Hall James & Associates’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
Rice Hall James & Associates's G Position: Q2 2026 in Review
Rice Hall James & Associates increased its Genpact (G) stake by 18% in Q2 2026, buying an estimated $4.27M and bringing the position to 833,996 shares worth $22.9M. The position accounts for 1.12% of the portfolio, ranked #27.
Rice Hall James & Associates first reported a position in G in Q4 2019 and has held it in 13 quarters since. The position peaked at $26.2M in Q1 2026. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.
- Rice Hall James & Associates held 833,996 shares of Genpact worth $22.9M as of Q2 2026.
- Rice Hall James & Associates bought 129,872 Genpact shares in Q2 2026, an estimated $4.27M.
- Genpact made up 1.12% of Rice Hall James & Associates's portfolio in Q2 2026, its #27 holding.
- Rice Hall James & Associates first reported a position in Genpact in Q4 2019 and has held it in 13 quarters since.
- Rice Hall James & Associates's Genpact position peaked at $26.2M in Q1 2026.
- 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.